122 related articles for article (PubMed ID: 36703541)
1. LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells.
Xie Y; Wang L; Luo Y; Chen H; Yang Y; Shen Q; Cao G
Biotechnol Genet Eng Rev; 2023 Jan; ():1-15. PubMed ID: 36703541
[TBL] [Abstract][Full Text] [Related]
2. Ginger inhibits the invasion of ovarian cancer cells SKOV3 through CLDN7, CLDN11 and CD274 m6A methylation modifications.
Zhang X; Zhang H; Zhu L; Xia L
BMC Complement Med Ther; 2024 Apr; 24(1):145. PubMed ID: 38575994
[TBL] [Abstract][Full Text] [Related]
3. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
4. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
[TBL] [Abstract][Full Text] [Related]
5. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
7. ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN.
Liu Z; Xu Z; Tian Y; Yan H; Lou Y
Onco Targets Ther; 2019; 12():3031-3042. PubMed ID: 31114246
[TBL] [Abstract][Full Text] [Related]
8. [Expression of METTL14 in epithelial ovarian cancer and the effect on cell proliferation, invasion and migration of A2780 and SKOV3 cells].
Wei YS; Yao DS; Li L; Lu Y; Yang XM; Zhang WG
Zhonghua Fu Chan Ke Za Zhi; 2022 Jan; 57(1):46-56. PubMed ID: 35090245
[No Abstract] [Full Text] [Related]
9. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung Cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
[TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68.
Nie Q; Wu X; Huang Y; Guo T; Kuang J; Du C
Eur J Med Res; 2023 Dec; 28(1):552. PubMed ID: 38042806
[TBL] [Abstract][Full Text] [Related]
12. m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.
Tian Q; Mu Q; Liu S; Huang K; Tang Y; Zhang P; Zhao J; Shu C
Carcinogenesis; 2023 Dec; 44(12):859-870. PubMed ID: 37738681
[TBL] [Abstract][Full Text] [Related]
13. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
14. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
[No Abstract] [Full Text] [Related]
16. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
17. OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway.
Xie W; Yu J; Yin Y; Zhang X; Zheng X; Wang X
Front Oncol; 2022; 12():876257. PubMed ID: 36033461
[TBL] [Abstract][Full Text] [Related]
18. METTL3/
Xiong J; Lian W; Zhao R; Gao K
Onco Targets Ther; 2024; 17():85-97. PubMed ID: 38348427
[TBL] [Abstract][Full Text] [Related]
19. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.
Li S; Zhao X; Chang S; Li Y; Guo M; Guan Y
Int J Oncol; 2019 Jan; 54(1):249-260. PubMed ID: 30431082
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
